Website stats for Tissuegene - tissuegene.com
This information—including product information—is intended only for residents of the United States. The products discussed on this site may have different labeling in different countries.
tissuegene.com was registered 2 decades 5 years ago. It is a domain having .com extension. It is estimated worth of $ 8.95 and have a daily income of around $ 0.15. As no active threats were reported recently, tissuegene.com is SAFE to browse.
Traffic Report
| Daily Unique Visitors: | Not Applicable |
| Daily Pageviews: | Not Applicable |
Estimated Valuation
| Income Per Day: | $ 0.15 |
| Estimated Worth: | $ 8.95 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | Not Applicable |
| Alexa BackLinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: |
 Very Poor
|
| WOT Privacy: |
Very Poor
|
| WOT Child Safety: |
Very Poor
|
Website Ranks & Scores
| Alexa Rank: | Not Applicable |
| PageSpeed Score: | 89 ON 100 |
| Domain Authority: |
49 ON 100 
|
| Bounce Rate: | Not Applicable |
| Time On Site: | Not Applicable |
Web Server Information
Hosted IP Address:
54.208.101.55
Hosted Country:
US
Location Latitude:
39.0437Location Longitude:
-77.4875Traffic Classification
| Total Traffic: | No Data |
| Direct Traffic: | No Data |
| Referral Traffic: | No Data |
| Search Traffic: | No Data |
| Social Traffic: | No Data |
| Mail Traffic: | No Data |
| Display Traffic: | No Data |
Search Engine Results For tissuegene.com
Kolon TissueGene - Overview, News & Competitors | ZoomInfo.com
Kolon TissueGene, Inc. is an advanced cell therapies company that has developed a first-in-class cell and gene therapy targeting OA of the knee.
Delisting of Kolon TissueGene drops bombshell on small investors
5 Nov 2020 ... Kolon TissueGene, an affiliate of Kolon Life Science under fire for controversial osteoarthritis treatment, Invossa-K, is about to be ...
Kolon TissueGene avoids delisting with 1-year grace period
1 Sept 2021 ... The Korea Exchange granted a one-year grace period for Kolon TissueGene, delaying the decision whether to delist the company from the Kosdaq ...
Kolon TissueGene Inc - Company Profile and News - Bloomberg.com
Kolon TissueGene, Inc. operates as a biopharmaceutical company. The Company develops novel advanced orthopedic disorders cell therapies, novel cell and gene ...
950160: Kolon TissueGene Inc Stock Price Quote - KOSDAQ
Kolon TissueGene, Inc. operates as a biopharmaceutical company. The Company develops novel advanced orthopedic disorders cell therapies, novel cell and gene ...
TissueGene Announces Company Name Change To ... - PR Newswire
16 Mar 2018 ... About TissueGene, Inc. TissueGene, Inc., is an advanced cell therapies company that has developed a first-in-class cell and gene therapy ...
Kolon Tissuegene Announces Plans To Resume US Phase III ...
13 Apr 2020 ... Kolon TissueGene, Inc. is an advanced cell therapies company that has developed a first-in-class cell and gene therapy targeting OA of the knee.
Kolon TissueGene, Inc. - CMOCRO
TissueGene, Inc. is a Maryland-based biopharmaceutical company focused on developing regenerative therapies for the treatment of various orthopedic ...
Kolon TissueGene Company Profile - Datanyze
Kolon TissueGene, Inc. is an advanced cell therapies company that has developed a first-in-class cell and gene therapy targeting OA of the knee.
Kolon TissueGene Company Profile - Office Locations ... - Craft.co
30 Jun 2021 ... Kolon TissueGene is a company developing cell therapies to target various orthopedic diseases and degenerative disorders.
Kolon TissueGene, Inc. (950160)
Kolon TissueGene is a Maryland-based biopharmaceutical company developing clinical-stage advanced cell therapies. ... This information—including product ...
Invossa™(Tissuegene-C) in patients with osteoarthritis: A phase III...
Purpose: Invossa™ (TissueGene-C) is a cell and gene therapy for osteoarthritis that contains non-transformed and transduced chondrocytes by the ratio of 3:1.
Horizon Scanning for Health Technologies Manual
INVOSSA™ (TISSUEGENE-C) induces an anti-inflammatory environment in the arthritic knee joints via macrophage polarization. Osteoarthritis and Cartilage.
758. TissueGene-C (TG-C), TGF-β1 Transduced Chondrocyte ...
758. TissueGene-C (TG-C), TGF-β1 Transduced Chondrocyte, Improved Clinical Scores in Patients With Osteoarthritis: A Phase 2b Study · Purpose. TG-C is a cell ...
Global Cell Therapy Market Report 2021 Featuring Fibrocell
30 Jun 2021 ... Ltd., Kolon TissueGene Inc., Stemedica Cell Technologies Inc., and AlloCure. The growth is mainly due to the companies resuming their ...
(PDF) TissueGene-C promotes an anti-inflammatory micro ...
23 Jul 2021 ... TissueGene-C (TG-C) is a novel cell and gene therapy for the treatment of OA, comprising a mixture of human allogeneic chondrocytes and ...
Kolon TissueGene, Inc. Email Formats & Employee Phones
Contact and general information about Kolon TissueGene, Inc. company, headquarter location in Rockville, Maryland. Email formats & phone numbers of Kolon ...
Pre-clinical studies of retrovirally transduced human chondrocytes ...
Pre-clinical studies of retrovirally transduced human chondrocytes expressing transforming growth factor-beta-1 (TG-C). Moon Jong Noh TissueGene Inc., Rockville ...
Study to Determine the Efficacy and Effectiveness of TG-C in ...
Kolon TissueGene, Inc. ClinicalTrials.gov Identifier: NCT03291470 History of Changes. Other Study ID Numbers: TGC15302. First Posted: September 25 ...
Kolon Tissuegene, Inc. in Rockville, MD - (301) 921-6000 - Buzzfile
Kolon Tissuegene, Inc. is in the Biotechnical Research, Commercial business. View competitors, revenue, employees, website and phone number.
TissueGene changes name to Kolon TissueGene, Inc.
19 Mar 2018 ... TissueGene, Inc. a leader in advanced cell and gene therapies targeting osteoarthritis (OA) announced the completion of the change of its ...
TissueGene Company Profile: Stock Performance & Earnings
Kolon TissueGene Inc is a biopharmaceutical company that develops regenerative therapies for the treatment of various orthopedic disorders.
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | 1 | H2 Headings: | 4 |
| H3 Headings: | Not Applicable | H4 Headings: | Not Applicable |
| H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
| Total IFRAMEs: | Not Applicable | Total Images: | 3 |
| Google Adsense: | Not Applicable | Google Analytics: | UA-81022424-1 |
Two Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| of the | 4 | 2.273 % | No |
| Kolon TissueGene | 3 | 1.705 % | No |
| advanced cell | 2 | 1.136 % | No |
| for the | 2 | 1.136 % | No |
| cell therapies | 2 | 1.136 % | No |
| the Treatment | 2 | 1.136 % | No |
| Treatment of | 2 | 1.136 % | No |
| Needs Kolon | 1 | 0.568 % | No |
| Orthopedic Disorders | 1 | 0.568 % | No |
| Medical Needs | 1 | 0.568 % | No |
| Unmet Medical | 1 | 0.568 % | No |
| and Unmet | 1 | 0.568 % | No |
| TissueGene is | 1 | 0.568 % | No |
| Disorders and | 1 | 0.568 % | No |
| a Marylandbased | 1 | 0.568 % | No |
| company developing | 1 | 0.568 % | No |
| developing clinicalstage | 1 | 0.568 % | No |
| biopharmaceutical company | 1 | 0.568 % | No |
| of Orthopedic | 1 | 0.568 % | No |
| Marylandbased biopharmaceutical | 1 | 0.568 % | No |
Four Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| for the Treatment of | 2 | 1.136 % | No |
| Unmet Medical Needs Kolon | 1 | 0.568 % | No |
| Medical Needs Kolon TissueGene | 1 | 0.568 % | No |
| Needs Kolon TissueGene is | 1 | 0.568 % | No |
| Kolon TissueGene is a | 1 | 0.568 % | No |
| and Unmet Medical Needs | 1 | 0.568 % | No |
| TissueGene is a Marylandbased | 1 | 0.568 % | No |
| of Orthopedic Disorders and | 1 | 0.568 % | No |
| Orthopedic Disorders and Unmet | 1 | 0.568 % | No |
| Disorders and Unmet Medical | 1 | 0.568 % | No |
| Treatment of Orthopedic Disorders | 1 | 0.568 % | No |
| is a Marylandbased biopharmaceutical | 1 | 0.568 % | No |
| clinicalstage advanced cell therapies | 1 | 0.568 % | No |
| advanced cell therapies INVOSSA™ | 1 | 0.568 % | No |
| cell therapies INVOSSA™ © | 1 | 0.568 % | No |
| developing clinicalstage advanced cell | 1 | 0.568 % | No |
| company developing clinicalstage advanced | 1 | 0.568 % | No |
| a Marylandbased biopharmaceutical company | 1 | 0.568 % | No |
| Marylandbased biopharmaceutical company developing | 1 | 0.568 % | No |
| biopharmaceutical company developing clinicalstage | 1 | 0.568 % | No |
Websites Hosted on Same IP (i.e. 54.208.101.55)
Antero Resources Corporation (AR)
Antero Resources is an independent natural gas and oil company engaged in the acquisition, development and production of unconventional liquids-rich natural gas properties...
Not Applicable 
$ 8.95
SeaChange International, Inc. (SEAC)
SeaChange International is a multinational supplier of Video Delivery Software Solutions that power cloud and on-premise video delivery platforms worldwide.
724,321 $ 1,920.00
HTTP Header Analysis
Status-Code: 200
Status: 200 OK
Date: Mon, 27 Sep 2021 15:26:27 GMT
Server: Apache
Expires: Thu, 19 Nov 1981 08:52:00 GMT
Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0
Pragma: no-cache
Vary: Accept-Encoding
Content-Encoding: gzip
Content-Length: 3767
Content-Type: text/html; charset=UTF-8
Domain Information
| Domain Registrar: |
GoDaddy.com, LLC
|
|---|---|
| Registration Date: | 1999-07-30 2 decades 5 years 3 months ago |
| Last Modified: | 2021-07-30 3 years 3 months 3 weeks ago |
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| ns1.p06.dynect.net | |
108.59.161.6 | United States |
| ns2.p06.dynect.net | |
108.59.162.6 | United States |
| ns3.p06.dynect.net | |
108.59.163.6 | United States |
| ns4.p06.dynect.net | |
108.59.164.6 | United States |
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| tissuegene.com | A | 3595 |
IP: 174.129.30.187 |
| tissuegene.com | A | 3595 |
IP: 54.208.101.55 |
| tissuegene.com | NS | 86400 |
Target: ns3.p06.dynect.net |
| tissuegene.com | NS | 86400 |
Target: ns2.p06.dynect.net |
| tissuegene.com | NS | 86400 |
Target: ns4.p06.dynect.net |
| tissuegene.com | NS | 86400 |
Target: ns1.p06.dynect.net |
| tissuegene.com | SOA | 3600 |
MNAME: ns1.p06.dynect.net RNAME: support.ntiva.com Serial: 8 Refresh: 3600 Retry: 600 Expire: 604800 |
| tissuegene.com | MX | 3600 |
Priority: 20 Target: tissuegene.com.2.0001.arsmtp.com |
| tissuegene.com | MX | 3600 |
Priority: 10 Target: tissuegene.com.1.0001.arsmtp.com |
| tissuegene.com | TXT | 3600 |
TXT: MS=ms20291707 |
| tissuegene.com | TXT | 3600 |
TXT: v=spf1 a ptr mx:webmail.tissuegene.com include:spf.protection.outlook.com include:mxlogic.net ip4:208.80.200.0/21 ~all |
| tissuegene.com | TXT | 3600 |
TXT: AAhH8/2qdkRv1iWDXkINCjm3cKM6IsUgssXnPtwJ oPvNz8oPUK6GZhPDeLn9pyDI6LWBZB55FatLFDx9 RWoSRw== |
| tissuegene.com | TXT | 3600 |
TXT: MS=65B63984551BF7263B3AF93A88D1AC32586A9 F32 |
Full WHOIS Lookup
Registry Domain ID:
8616674_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.godaddy.com
Registrar URL:
http://www.godaddy.com
Updated Date:
2021-07-30T12:42:04Z
Creation Date:
1999-07-30T03:42:33Z
Registry Expiry Date:
2022-07-30T03:42:30Z
Registrar: GoDaddy.com, LLC
Registrar
IANA ID: 146
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
480-624-2505
Domain Status: clientDeleteProhibited
https://icann.org/epp#clientDeleteProhibited
Domain Status:
clientRenewProhibited
https://icann.org/epp#clientRenewProhibited
Domain Status:
clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Domain Status:
clientUpdateProhibited
https://icann.org/epp#clientUpdateProhibited
Name Server:
NS1.P06.DYNECT.NET
Name Server: NS2.P06.DYNECT.NET
Name
Server: NS3.P06.DYNECT.NET
Name Server:
NS4.P06.DYNECT.NET
DNSSEC: unsigned
URL of the ICANN Whois
Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last
update of whois database: 2021-09-27T15:26:22Z
Similarly Ranked Websites
Google Chrome - Download the Fast, Secure Browser from Google
Get more done with the new Google Chrome. A more simple, secure, and faster web browser than ever, with Google’s smarts built-in. Download now.
1 $ 16,097,351,400.00
Log into Facebook
Log into Facebook to start sharing and connecting with your friends, family, and people you know.
4 $ 4,024,338,120.00
腾讯网
腾讯网从2003年创立至今，已经成为集新闻信息，区域垂直生活服务、社会化媒体资讯和产品为一体的互联网媒体平台。腾讯网下设新闻、科技、财经、娱乐、体育、汽车、时尚等多个频道，充分满足用户对不同类型资讯的需求。同时专注不同领域内容，打造精品栏目，并顺应技术发展趋势，推出网络直播等创新形式，改变了用户获取资讯的方式和习惯。
5 $ 3,219,470,280.00
Amazon.com. Spend less. Smile more.
- amazon.com
Free shipping on millions of items. Get the best of Shopping and Entertainment with Prime. Enjoy low prices and great deals on the largest selection of everyday essentials and...
7 $ 2,299,621,320.00